Effectiveness of training general practitioners to improve the implementation of brief stop-smoking advice in German primary care: study protocol of a pragmatic, 2-arm cluster randomised controlled trial (the ABCII trial).
Brief smoking cessation advice
General practitioner
National practice guideline
Primary care
Tobacco addiction
Journal
BMC family practice
ISSN: 1471-2296
Titre abrégé: BMC Fam Pract
Pays: England
ID NLM: 100967792
Informations de publication
Date de publication:
27 07 2019
27 07 2019
Historique:
received:
08
11
2018
accepted:
27
06
2019
entrez:
29
7
2019
pubmed:
29
7
2019
medline:
9
4
2020
Statut:
epublish
Résumé
The German clinical guideline on tobacco addiction recommends that general practitioners (GPs) provide brief stop-smoking advice to their patients according to the "5A" or the much briefer "ABC" method, but its implementation is insufficient. A lack of training is one barrier for GPs to provide such advice. Moreover, the respective effectiveness of a 5A or ABC training regarding subsequent delivery of stop-smoking advice has not been investigated. We developed a training for GPs according to both methods, and conducted a pilot study with process evaluation to optimize the trainings according to the needs of GPs. This study aims at evaluating the effectiveness of both trainings. A pragmatic 2-arm cluster randomised controlled trial with a pre-post data collection will be conducted in 48 GP practices in North Rhine-Westphalia (Germany). GPs will be randomised to receive a 3.5-h-training in delivering either 5A or ABC, including peer coaching and intensive role plays with professional actors. The patient-reported primary outcome (receipt of GP advice to quit: yes/no) and secondary outcomes (recommendation rates of smoking cessation treatments, group comparison (5A versus ABC): receipt of GP advice to quit) will be collected in smoking patients routinely consulting their GP within 4 weeks prior, and 4 weeks following the training. Additional secondary outcomes will be collected at 4, 12 and 26 weeks following the consultation: use of cessation treatments during the last quit attempt (if so) since the GP consultation, and point-prevalence abstinence rates. The primary data analysis will be conducted using a mixed-effects logistic regression model with random effects for the cluster variable. If the training increases the rates of delivery of stop-smoking advice, it would offer a low-threshold strategy for the guideline implementation in German primary care. Should one method prove superior, a more specific guideline recommendation can be proposed. German Clinical Trials Register (DRKS00012786); registered on 22th August 2017, prior to the first patient in.
Sections du résumé
BACKGROUND
The German clinical guideline on tobacco addiction recommends that general practitioners (GPs) provide brief stop-smoking advice to their patients according to the "5A" or the much briefer "ABC" method, but its implementation is insufficient. A lack of training is one barrier for GPs to provide such advice. Moreover, the respective effectiveness of a 5A or ABC training regarding subsequent delivery of stop-smoking advice has not been investigated. We developed a training for GPs according to both methods, and conducted a pilot study with process evaluation to optimize the trainings according to the needs of GPs. This study aims at evaluating the effectiveness of both trainings.
METHODS
A pragmatic 2-arm cluster randomised controlled trial with a pre-post data collection will be conducted in 48 GP practices in North Rhine-Westphalia (Germany). GPs will be randomised to receive a 3.5-h-training in delivering either 5A or ABC, including peer coaching and intensive role plays with professional actors. The patient-reported primary outcome (receipt of GP advice to quit: yes/no) and secondary outcomes (recommendation rates of smoking cessation treatments, group comparison (5A versus ABC): receipt of GP advice to quit) will be collected in smoking patients routinely consulting their GP within 4 weeks prior, and 4 weeks following the training. Additional secondary outcomes will be collected at 4, 12 and 26 weeks following the consultation: use of cessation treatments during the last quit attempt (if so) since the GP consultation, and point-prevalence abstinence rates. The primary data analysis will be conducted using a mixed-effects logistic regression model with random effects for the cluster variable.
DISCUSSION
If the training increases the rates of delivery of stop-smoking advice, it would offer a low-threshold strategy for the guideline implementation in German primary care. Should one method prove superior, a more specific guideline recommendation can be proposed.
TRIAL REGISTRATION
German Clinical Trials Register (DRKS00012786); registered on 22th August 2017, prior to the first patient in.
Identifiants
pubmed: 31351460
doi: 10.1186/s12875-019-0986-8
pii: 10.1186/s12875-019-0986-8
pmc: PMC6660716
doi:
Banques de données
DRKS
['DRKS00012786']
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
107Références
Eur J Public Health. 2017 Feb 1;27(1):129-134
pubmed: 28177479
Gesundheitswesen. 2016 Nov;78(11):752-758
pubmed: 26158343
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
J Clin Epidemiol. 2015 Jun;68(6):693-7
pubmed: 25450450
Eur J Cardiovasc Prev Rehabil. 2011 Apr;18(2):334-41
pubmed: 21450679
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
BMC Med Educ. 2010 Mar 31;10:27
pubmed: 20353612
Tob Control. 2008 Jun;17(3):173-6
pubmed: 18522969
Nicotine Tob Res. 2014 Jan;16(1):1-10
pubmed: 23873981
BMJ Open. 2015 Feb 18;5(2):e007166
pubmed: 25694460
PLoS One. 2016 Dec 21;11(12):e0168482
pubmed: 28002498
Addiction. 2015 Mar;110(3):387-8
pubmed: 25678284
Tob Induc Dis. 2017 Nov 2;15:41
pubmed: 29142531
Patient Educ Couns. 2006 Oct;63(1-2):232-8
pubmed: 16531000
J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Eur J Gen Pract. 2013 Jun;19(2):99-105
pubmed: 23514137
Dtsch Arztebl Int. 2018 Apr 6;115(14):235-242
pubmed: 29716687
Addiction. 2017 Dec;112(12):2237-2247
pubmed: 28667826
Tob Control. 2017 Jul;26(4):455-457
pubmed: 27377343
N Engl J Med. 2008 Jun 5;358(23):2468-81
pubmed: 18525043
JAMA Intern Med. 2015 Sep;175(9):1509-16
pubmed: 26076313
BMC Fam Pract. 2013 Jul 30;14:108
pubmed: 23899116
Addiction. 2004 Jan;99(1):29-38
pubmed: 14678060
Addiction. 2011 Mar;106(3):631-8
pubmed: 21134020
Drug Alcohol Depend. 2013 Feb 1;128(1-2):15-9
pubmed: 22943961
Nicotine Tob Res. 2002 May;4(2):149-59
pubmed: 12028847
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
N Engl J Med. 2013 Jan 24;368(4):341-50
pubmed: 23343063
Tob Control. 2007 Feb;16(1):15-21
pubmed: 17297068
Eur J Public Health. 2005 Apr;15(2):140-5
pubmed: 15941758
BMJ. 2006 Feb 25;332(7539):458-60
pubmed: 16443610
Health Educ Behav. 2018 Dec;45(6):888-897
pubmed: 29862845
Nicotine Tob Res. 2018 Nov 15;20(12):1525-1528
pubmed: 29099979
Cochrane Database Syst Rev. 2012 May 16;(5):CD000214
pubmed: 22592671
Addiction. 2015 Sep;110(9):1388-403
pubmed: 26031929
Cochrane Database Syst Rev. 2013 May 31;(5):CD000165
pubmed: 23728631
Addiction. 2012 Oct;107(10):1878-82
pubmed: 22551065
BMJ. 2013 Aug 19;347:f4921
pubmed: 23963106
Addiction. 2008 Feb;103(2):294-304
pubmed: 17995993
Am J Prev Med. 2008 Aug;35(2):158-76
pubmed: 18617085